References
- Groen JL, Kawarai T, Toulina A, et al. Genetic association study of PINK1 coding polymorphisms in Parkinson's disease. Neurosci Lett 2004;372(3):226–9.
- Xu X, Li D, He Q, et al. Interleukin-18 promoter polymorphisms and risk of Parkinson's disease in a Han Chinese population. Brain Res 2011;1381:90–4.
- Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44(4):601–7.
- Tang B, Xiong H, Sun P, et al. Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet 2006;15(11):1816–25.
- Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605–8.
- Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304(5674):1158–60.
- Winkler S, Hagenah J, Lincoln S, et al. alpha-Synuclein and Parkinson disease susceptibility. Neurology 2007;69(18):1745–50.
- Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010;42(9):781–5.
- Hill-Burns EM, Factor SA, Zabetian CP, et al. Evidence for more than one Parkinson's disease-associated variant within the HLA region. PLoS One 2011;6(11):e27109.
- Mata IF, Yearout D, Alvarez V, et al. Replication of MAPT and SNCA, but not PARK16–18, as susceptibility genes for Parkinson's disease. Mov Disord 2011;26(5):819–23.
- Sharma M, Ioannidis JP, Aasly JO, et al. Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 2012;79(7):659–67.
- Guo Y, Deng X, Zheng W, et al. HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease. Neurosci Lett 2011;501(3):185–7.
- Zhao Y, Gopalai AA, Ahmad-Annuar A, et al. Association of HLA locus variant in Parkinson's disease. Clin Genet 2013;84(5):501–4.
- Zhou LL, Zhang X, Bao QQ, et al. Association analysis of PARK16–18 variants and Parkinson's disease in a Chinese population. J Clin Neurosci 2014;21(6):1029–32.
- Chiang HL, Lee-Chen GJ, Chen CM, et al. Genetic analysis of HLA-DRA region variation in Taiwanese Parkinson's disease. Parkinsonism Relat Disord. 2012;18(4):391–3.
- Lin CH, Chen ML, Tai YC, et al. Reaffirmation of GAK, but not HLA-DRA, as a Parkinson's disease susceptibility gene in a Taiwanese population. Am J Med Genet B Neuropsychiatr Genet 2013;162B(8):841–6.
- McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988;38(8):1285–91.
- Tansey MG, McCoy MK, Frank-Cannon TC. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 2007;208(1):1–25.
- Montgomery SB, Sammeth M, Gutierrez-Arcelus M, et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 2010;464(7289):773–7.
- Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007;39(10):1217–24.
- Hill-Burns EM, Wissemann WT, Hamza TH, et al. Identification of a novel Parkinson's disease locus via stratified genome-wide association study. BMC Genomics 2014;15(1):118.
- Ran C, Willows T, Sydow O, et al. The HLA-DRA variation rs3129882 is not associated with Parkinson's disease in Sweden. Parkinsonism Relat Disord 2013;19(7):701–2.